<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02891655</url>
  </required_header>
  <id_info>
    <org_study_id>EGN_2016_6</org_study_id>
    <nct_id>NCT02891655</nct_id>
  </id_info>
  <brief_title>KERatoconus and Metalloproteinases InvesTigation</brief_title>
  <acronym>KERMIT</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <brief_summary>
    <textblock>
      Corneal stromal thinning observed in keratoconic eyes could result from an increased
      synthesis of MMP at the level of the anterior stroma and the corneal epithelium induced by an
      overexpression of the Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) and Galectin-3
      by epithelial cells. A differential expression of EMMPRIN, Galectin-3 and metalloproteinases
      (MMP) may be observed between the apex of the keratoconus and the peripheral cornea.
      Highlighting the implication of EMMPRIN and Galectin-3 could lead to the development of
      specific inhibitors to slow or to stop keratoconus evolution.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2, 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>expression of the Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) in epithelial cells</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Keratoconus</condition>
  <arm_group>
    <arm_group_label>surgery for keratoconus</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>refractive surgery (control patients)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>immuno-histo-chemical analysis</intervention_name>
    <description>in vitro immuno-histo-chemical analysis of corneal epithelium</description>
    <arm_group_label>surgery for keratoconus</arm_group_label>
    <arm_group_label>refractive surgery (control patients)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with keratoconus and controls subjects without keratoconus
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years old

          -  Patient with keratoconus undergoing corneal collagen cross-linking (epithelium-off
             methods)

          -  Patient with keratoconus undergoing his first corneal graft for optical indication
             (control)

        Exclusion Criteria:

          -  Patient with keratoconus undergoing corneal graft for tectonic indication

          -  Patient undergoing corneal refractive surgery (refractive photokeratectomy) with a
             normal topography, a normal slit lamp examination and no previous ophthalmic condition
             (control)

          -  pregnant or breast feeding patient

          -  patient under judiciary protection

          -  patient opposition to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric GABISON, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation OPH A de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence SALOMON, MD, PhD</last_name>
    <phone>0033148036431</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondation Opthalmologique A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric GABISON</last_name>
      <email>egabison@for.paris</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2016</study_first_submitted>
  <study_first_submitted_qc>September 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2016</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

